17-34983072-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 2P and 11B. PM2BP4_StrongBP6_ModerateBP7BS1
The NM_013975.4(LIG3):c.67C>T(p.Leu23Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000191 in 1,613,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_013975.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 154AN: 151936Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000315 AC: 79AN: 251192Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135766
GnomAD4 exome AF: 0.000107 AC: 156AN: 1461614Hom.: 0 Cov.: 34 AF XY: 0.0000908 AC XY: 66AN XY: 727102
GnomAD4 genome AF: 0.00101 AC: 153AN: 152054Hom.: 0 Cov.: 32 AF XY: 0.00105 AC XY: 78AN XY: 74310
ClinVar
Submissions by phenotype
not provided Benign:1
Variant summary: The LIG3 c.67C>T (p.Leu23Leu) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in the large control database ExAC in 45/120194 control chromosomes, predominantly observed in the African subpopulation at a frequency of 0.004169 (43/10314). This frequency is about 417 times the estimated maximal expected allele frequency of a pathogenic LIG3 variant (0.00001), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at